BioLife Solutions Inc. (BLFS) is a publicly traded Healthcare sector company. As of May 21, 2026, BLFS trades at $24.00 with a market cap of $1.09B and a P/E ratio of -401.10. BLFS moved +4.43% today. Year to date, BLFS is -5.18%; over the trailing twelve months it is +5.22%. Its 52-week range spans $17.86 to $29.62. Analyst consensus is strong buy with an average price target of $33.00. Rallies surfaces BLFS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading BLFS stock inside the company?
Recent BLFS insider activity includes Foster Karen A. sold 2.58K, Foster Karen A. sold 500, Foster Karen A. sold 96.92K, Werner Sean sold 111, and Foster Karen A. sold 418. Rallies tracks insider transaction dates, shares, prices, and estimated values.
BLFS Key Metrics
Key financial metrics for BLFS
Metric
Value
Price
$24.00
Market Cap
$1.09B
P/E Ratio
-401.10
EPS
$-0.06
Dividend Yield
0.00%
52-Week High
$29.62
52-Week Low
$17.86
Volume
947
Avg Volume
0
Revenue (TTM)
$99.77M
Net Income
$-2.96M
Gross Margin
64.96%
Recent BLFS Insider Trades
Foster Karen A. sold 2.58K (~$49.40K) on Mar 23, 2026.
Foster Karen A. sold 500 (~$10.00K) on Mar 9, 2026.
Foster Karen A. sold 96.92K (~$1.95M) on Mar 5, 2026.
Werner Sean sold 111 (~$2.30K) on Mar 3, 2026.
Foster Karen A. sold 418 (~$8.67K) on Mar 3, 2026.
Recent BLFS insider activity includes Foster Karen A. sold 2.58K, Foster Karen A. sold 500, Foster Karen A. sold 96.92K, Werner Sean sold 111, and Foster Karen A. sold 418. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for BLFS?
Yes. Rallies tracks BLFS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is BLFS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BLFS. It does not provide personalized investment advice.
